Related Experiment Video
Updated: Jun 19, 2026

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
Published on: April 18, 2015
Model-based blind estimation of kinetic parameters in dynamic contrast enhanced (DCE)-MRI
Jacob U Fluckiger1, Matthias C Schabel, Edward V R Dibella
1Utah Center for Advanced Imaging Research, Department of Radiology, University of Utah, Salt Lake City, Utah, USA. j.fluckiger@utah.edu
This study presents a new method for analyzing dynamic contrast-enhanced MRI scans, accurately estimating the arterial input function (AIF) and pharmacokinetic parameters in tumors. The developed algorithm improves DCE-MRI analysis for cancer research.
Area of Science:
- Medical Imaging
- Biophysics
- Pharmacokinetics
Background:
- Dynamic contrast-enhanced MRI (DCE-MRI) is crucial for assessing tissue perfusion and vascularity.
- Accurate estimation of the arterial input function (AIF) is essential for reliable pharmacokinetic modeling in DCE-MRI.
- Current methods for AIF estimation can be complex and may require invasive procedures.
Purpose of the Study:
- To develop and validate a novel, non-invasive method for simultaneously estimating the AIF and pharmacokinetic parameters from DCE-MRI data.
- To assess the accuracy and robustness of the proposed algorithm using computer simulations and clinical data from sarcoma patients.
Main Methods:
- Developed an iterative blind estimation algorithm utilizing a parameterized functional form for AIF modeling.
- Employed k-means clustering to categorize tissue time-concentration measurements into characteristic curves.
- Validated the method through computer simulations assessing noise sensitivity and initial estimate impact.
- Compared estimated pharmacokinetic parameters (Ktrans, kep) with reference values derived from a measured AIF in 12 sarcoma patients.
Main Results:
- The algorithm successfully estimated AIF and pharmacokinetic parameters simultaneously from DCE-MRI data.
- In sarcoma patients, estimated Ktrans and kep values showed no significant difference compared to reference values (P=0.27 and P=0.08, respectively).
- Inclusion of arterial voxels in the blind estimation yielded an AIF comparable to the measured input function.
Conclusions:
- The developed iterative blind estimation algorithm provides accurate and reliable simultaneous estimation of AIF and pharmacokinetic parameters in DCE-MRI.
- This method offers a robust alternative for quantitative analysis of DCE-MRI data, particularly in oncology applications.
- Further investigation is warranted for AIF estimation in specific scenarios, such as when excluding vascular contributions, which may reflect local AIF characteristics.
More Related Videos
08:59Use of a Multi-compartment Dynamic Single Enzyme Phantom for Studies of Hyperpolarized Magnetic Resonance Agents
Published on: April 15, 2016
07:28Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level
Published on: January 24, 2025